Page 3 - Les meilleurs doctors traitant la maladie suivante : Cancer de l'utérus - TOP -102 des médecins

Le Dr Topcu est spécialisé dans le traitement du cancer de l'utérus, avec une vaste formation internationale dans de prestigieux centres d'oncologie tels que le MD Anderson et le Moffit.

• Spécialiste en oncologie médicale avec plus de 15 ans d'expérience
• Formé au MD Anderson Cancer Center et au Sunnybrook Odette Cancer Center
• Expert en cancers gynécologiques, y compris ceux de l'utérus et des ovaires
• Exerce aux Valued Med Hub Hospitals

Spécialiste des cancers urogénitaux axé sur les traitements fondés sur la recherche – Le Dr Sec est le représentant des médecins spécialistes de l'Association Turque d'Oncologie Médicale.

• Plus de 5 ans d'expérience en oncologie médicale
• Publication de plusieurs études sur les résultats des traitements contre le cancer
• Membre de l'Association Turque d'Oncologie Médicale
• Travailler à l'hôpital Bahçelievler Medikalpark

Le Dr Rabin coordonne les soins oncologiques à l'hôpital Sheba de Tel Hashomer et a été formé au prestigieux MD Anderson Cancer Center.

• Achever l'internat en oncologie et radiothérapie
• Fellowship en oncologie gynécologique au MD Anderson
• Vaste expérience dans le traitement des tumeurs du système reproducteur féminin
• Chercheur dans la recherche sur l'ablation par ultrasons guidée par IRM
• Membre de l'American Society for Radiation Oncology

Le professeur associé Tahsin Ozatli est spécialisé dans les cancers du sein, du poumon et gastro-intestinaux à l'hôpital universitaire Istinye Liv.

• Plus de 10 ans d'expérience en oncologie
• Formation à la faculté de médecine de l'université de Selcuk
• A travaillé précédemment à la clinique d'oncologie d'Ankara
• Promu professeur associé en 2016

Le Dr Viola Fox dirige la clinique d'hématologie, d'oncologie et de soins palliatifs du BKZ Solingen, se spécialisant dans les traitements avancés du cancer de l'utérus.

• Hématologue, oncologue et immunologiste certifiée avec plus de 13 ans d'expérience
• Experte en chimiothérapie, immunothérapie et thérapies ciblées
• Spécialiste qualifiée en génétique pour des plans de traitement personnalisés
• Active dans la recherche en biologie moléculaire pour des thérapies innovantes contre le cancer
• Membre de sociétés d'oncologie allemandes et américaines

Le professeur Keil se spécialise dans les techniques d'imagerie avancées pour le cancer de l'utérus, s'appuyant sur sa formation approfondie dans les meilleurs hôpitaux allemands.

• Obtenir son diplôme avec mention à l'Université Julius-Maximilian de Wurtzbourg
• Être expert en IRM, scanner et échographie pour les interventions complexes
• Être médecin-chef à l'Hôpital Académique de Solingen depuis 2022
• Ancien médecin principal au Centre Hospitalier Universitaire d'Aix-la-Chapelle

Le Prof. Cemil Bilir est spécialisé dans le cancer de l'utérus, avec une double expertise en oncologie médicale et en recherche en chimie inorganique.

• Plus de 18 ans d'expérience en oncologie avec une formation spécialisée à la Cleveland Clinic
• Professeur à l'Université de Sakarya – leader dans l'enseignement de l'oncologie
• Membre de l'ASCO, de l'ESMO et de la Société Turque d'Oncologie Médicale
• Mener des recherches sur le cancer parallèlement à la pratique clinique

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Le professeur associé Nail Paksoy est spécialisé dans le traitement du cancer de l'utérus à l'hôpital Medipol Bahçelievler, avec des recherches approfondies en oncologie gynécologique.

• Certifié par l'ESMO en oncologie médicale
• Publier de nombreuses études sur les traitements du cancer de l'endomètre
• Participer à des essais cliniques internationaux pour le cancer de l'endomètre avancé
• Effectuer un stage de spécialisation à l'Institut d'oncologie de l'Université d'Istanbul

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Le Dr Inta Jaunalksne se spécialise en virothérapie, un domaine de pointe de l'immunologie, avec plus de 30 ans d'expérience.

• Chef du centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Diplômée de l'Institut de médecine de Riga avec un internat en médecine interne
• Se concentrer sur les traitements immunologiques innovants

Le Dr Alemdar se spécialise dans le cancer de l'utérus avec une formation approfondie en oncologie médicale de l'Université Akdeniz.

• Plus de 15 ans d'expérience en oncologie
• Formé à l'Université Akdeniz, une institution médicale de premier plan
• Travailler au complexe hospitalier Medical Park Antalya

Le Dr Ozden apporte plus de 20 ans d'expérience médicale, se spécialisant en oncologie avec un accent sur le cancer de l'utérus à l'hôpital VM Medical Park Pendik.

• Diplômé de la prestigieuse faculté de médecine Cerrahpaşa de l'université d'Istanbul
• Spécialisation en oncologie médicale complétée à l'université de Kocaeli
• Vaste expérience dans le secteur hospitalier public et privé
• Pratique de la médecine interne avant de se spécialiser en oncologie

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Hisham Khalifa is a Consultant Surgical Oncologist. He assesses, diagnoses, and operates on gynecological cancers, including ovarian, uterine, cervical, vaginal, and vulval cancers. He performs both minimally invasive (laparoscopic) and open surgery.

Career milestones: Resident and faculty member at the National Cancer Institute, Cairo University (2001–2014). Assistant Professor at AlFaisal University and Assistant Consultant at King Faisal Hospital and Research Center (KFSHRC), Riyadh (2014–2019). Consultant at the NCI, Cairo (2019–present); Director of the Professional Diploma in Gyne-Onco Surgery. Consultant at the Oncology Pediatric Hospital–Alexandria University and Shefa Al Orman Comprehensive Cancer Center, Luxor (2020–present).

Credentials: MBBCh (1999); Master’s in General Surgery (2004); Doctorate in Surgical Oncology (2008); Fellowship of the European Board of Surgery (FEBS, UEMS). Memberships: FACS; SSO; ESSO; ECS; EGSSO.